COVID-19 and Darwin’s Natural Selection among Humans

With the advent of COVID-19, there seems to be a negative selection pressure working against those who may be genetically or otherwise (due to their lifestyle, co-morbidities etc.) predisposed to develop severe symptoms, ultimately leading to death. Majority of people are either unaffected or develop mild to moderate symptoms and survive. It is less than 5% of population who suffer high risk of severe symptoms, damage to lungs and consequent mortality. The way the variants are evolving, particularly how it happened in Italy at the beginning of pandemic and current happenings in India seem to suggest that the population predisposed to develop severe symptoms run the risk of elimination. This becomes even more pertinent particularly in the context of possible ineffectiveness of the currently available vaccines against ever mutating virus. Will a population finally emerge that will be naturally immune to SARS-CoV 2 Virus?  

Darwin’s theory of natural selection and the origin of new species played a key role in origin of modern man. There was a continuous negative selection pressure, in the wild natural world we lived in, against those individuals that were unfit to survive in the new and changing environment. Those with the desired suitable characteristics were favoured by the nature and went on to survive and procreate. In due course of time, these suitable characteristics accumulated in progenies giving rise to a population that was markedly different from the former.  

However, this process of survival of the fittest almost came to grind halt with the growth of human civilisation and industrialization. Welfare state and advances in the medical sciences meant that people who otherwise would not have survived due to negative selection pressure against them, survived and procreated. This almost led to a pause in the natural selection among humans. Actually, it may have led to the creation of artificial selection among human species. 

With the advent of COVID-19, there seems to be a negative selection pressure working against those who may be genetically or otherwise (due to their lifestyle, co-morbidities etc.) predisposed to develop severe symptoms, ultimately leading to death. Majority of people are either unaffected or develop mild to moderate symptoms and survive. It is less than 5% of population who suffer high risk of severe symptoms, damage to lungs and consequent mortality. The way the variants are evolving, particularly how it happened in Italy at the beginning of pandemic and current happenings in India seem to suggest that the population predisposed to develop severe symptoms run the risk of elimination. This becomes even more pertinent particularly in the context of possible ineffectiveness of the currently available vaccines against ever mutating virus.   

Apparently, COVID-19 seems to have re-started natural selection among human beings.  

***

Latest

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Newsletter

Don't miss

Intermittent Fasting or Time-Restricted Feeding (TRF) Has Significant Negative Effects on Hormones

Intermittent fasting has a wide range of effects on...

A Virtual Large Library to Assist Rapid Drug Discovery and Design

Researchers have built a large virtual docking library which...

Lolamicin: The Selective antibiotic against Gram-negative infections that spares gut microbiome  

Current antibiotics used in clinical practice, in addition to...

European COVID-19 Data Platform: EC Launched Data Sharing Platform for Researchers

The European Commission has launched www.Covid19DataPortal.org where the researchers can store...

WHO’s Interim recommendations for the use of One-dose Janssen Ad26.COV2.S (COVID-19) vaccine

Single dose of the vaccine can increase vaccine coverage rapidly...

Mass of Neutrinos is less than 0.8 eV

KATRIN experiment mandated to weigh neutrinos has announced a...
Umesh Prasad
Umesh Prasad
Umesh Prasad is a researcher-communicator who excels at synthesizing peer-reviewed primary studies into concise, insightful, and well-sourced public articles. A specialist in knowledge translation, he is driven by a mission to make science inclusive for non-English speaking audiences. Toward this goal, he founded “Scientific European,” this innovative, multilingual, open-access digital platform. By addressing a critical gap in global science dissemination, Prasad acts as a key knowledge curator whose work represents a sophisticated new era of scholarly journalism, bringing the latest research to the doorstep of common people in their native languages.

Neanderthals Performed Dental Caries Interventions 59,000 Years Ago

Prehistoric dentistry is far older than 14,000 years as indicated by Villabruna specimen from Late Upper Palaeolithic era. A recent study on 59,000-year-old Neanderthal...

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...